BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12712724)

  • 1. [Relationship between unhealthy dietary behavior and blood lipids and lipid peroxides in coronary heart disease patients].
    Guan Z; Zhou Z; Sun M; Huang F
    Wei Sheng Yan Jiu; 1999 May; 28(3):167-9. PubMed ID: 12712724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
    Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
    Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
    Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
    Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
    Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
    Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of blood lipids and lipoproteins with coronary artery disease documented by angiography.
    Qian XX; Wei DZ; Wen Y; Chen SL; Jia GL; Jin YF; Li HZ; Peng HZ
    Chin Med J (Engl); 1990 May; 103(5):380-4. PubMed ID: 2118054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
    Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
    Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
    Nam BH; Kannel WB; D'Agostino RB
    Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for coronary heart disease risk in the elderly: total cholesterol versus high-density lipoprotein-cholesterol.
    Kligman EW; Watkins AJ
    Am J Prev Med; 1991; 7(5):263-7. PubMed ID: 1790030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of pearl layer powder on lipid peroxides and lipids in coronary disease patients].
    Huang YW
    Zhong Xi Yi Jie He Za Zhi; 1987 Oct; 7(10):596-7, 580. PubMed ID: 3447759
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
    Rubins HB; Schectman G; Wilt TJ; Iwane MK
    Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL cholesterol predicts coronary heart disease mortality in older persons.
    Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of testosterone/estradiol promotes male CHD development.
    Zheng HY; Li Y; Dai W; Wei CD; Sun KS; Tong YQ
    Biomed Mater Eng; 2012; 22(1-3):179-85. PubMed ID: 22766718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The evaluation of lipoprotein as a screening test for coronary heart disease].
    Li SC
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Jun; 10(3):167-71. PubMed ID: 2776196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.